CRISPR Therapeutics AG (CRSP) Current Reports & Earnings Releases
Upcoming
- 2026-11-09 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-03 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-16 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-03-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Other Events | SEC |
| 2025-11-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-26 | 8-K | Other Events | SEC |
| 2025-06-09 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-19 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-26 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-02-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-03 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-23 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-21 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-13 | 8-K | Other Events | SEC |
| 2024-02-13 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-16 | 8-K | Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.